Global Multivalent Oral Rotavirus Vaccine Market Growth 2026-2032
The global Multivalent Oral Rotavirus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The multivalent oral rotavirus vaccine is specifically designed to prevent gastrointestinal infections caused by rotavirus. This vaccine effectively stimulates the immune system in children, reducing the risk of severe diarrhea, dehydration, and hospitalization, as rotavirus is a significant cause of gastroenteritis in infants and young children worldwide. Administered orally, it contains multiple attenuated or inactivated strains of the rotavirus, aiming to provide broad immune protection against different types of rotavirus.
United States market for Multivalent Oral Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Multivalent Oral Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Multivalent Oral Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Multivalent Oral Rotavirus Vaccine players cover Merck, Lanzhou Institute of Biological Products, Serum Institute of India, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Multivalent Oral Rotavirus Vaccine Industry Forecast” looks at past sales and reviews total world Multivalent Oral Rotavirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Multivalent Oral Rotavirus Vaccine sales for 2026 through 2032. With Multivalent Oral Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multivalent Oral Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Multivalent Oral Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multivalent Oral Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multivalent Oral Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multivalent Oral Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multivalent Oral Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Multivalent Oral Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Multivalent Oral Rotavirus Vaccine market?
What factors are driving Multivalent Oral Rotavirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Multivalent Oral Rotavirus Vaccine market opportunities vary by end market size?
How does Multivalent Oral Rotavirus Vaccine break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
The multivalent oral rotavirus vaccine is specifically designed to prevent gastrointestinal infections caused by rotavirus. This vaccine effectively stimulates the immune system in children, reducing the risk of severe diarrhea, dehydration, and hospitalization, as rotavirus is a significant cause of gastroenteritis in infants and young children worldwide. Administered orally, it contains multiple attenuated or inactivated strains of the rotavirus, aiming to provide broad immune protection against different types of rotavirus.
United States market for Multivalent Oral Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Multivalent Oral Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Multivalent Oral Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Multivalent Oral Rotavirus Vaccine players cover Merck, Lanzhou Institute of Biological Products, Serum Institute of India, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Multivalent Oral Rotavirus Vaccine Industry Forecast” looks at past sales and reviews total world Multivalent Oral Rotavirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Multivalent Oral Rotavirus Vaccine sales for 2026 through 2032. With Multivalent Oral Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multivalent Oral Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Multivalent Oral Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multivalent Oral Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multivalent Oral Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multivalent Oral Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multivalent Oral Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Multivalent Oral Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- RV3
- RV5
- Government Institution
- Private Sector
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Lanzhou Institute of Biological Products
- Serum Institute of India
What is the 10-year outlook for the global Multivalent Oral Rotavirus Vaccine market?
What factors are driving Multivalent Oral Rotavirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Multivalent Oral Rotavirus Vaccine market opportunities vary by end market size?
How does Multivalent Oral Rotavirus Vaccine break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Multivalent Oral Rotavirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Multivalent Oral Rotavirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Multivalent Oral Rotavirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Multivalent Oral Rotavirus Vaccine Segment by Type
2.2.1 RV3
2.2.2 RV5
2.2.3 Multivalent Oral Rotavirus Vaccine Sales by Type
2.2.3.1 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Multivalent Oral Rotavirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Multivalent Oral Rotavirus Vaccine Sale Price by Type (2021-2026)
2.3 Multivalent Oral Rotavirus Vaccine Segment by Application
2.3.1 Government Institution
2.3.2 Private Sector
2.3.3 Other
2.3.4 Multivalent Oral Rotavirus Vaccine Sales by Application
2.3.4.1 Global Multivalent Oral Rotavirus Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Multivalent Oral Rotavirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Multivalent Oral Rotavirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Multivalent Oral Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Multivalent Oral Rotavirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Multivalent Oral Rotavirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Multivalent Oral Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Multivalent Oral Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Multivalent Oral Rotavirus Vaccine Product Location Distribution
3.4.2 Players Multivalent Oral Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MULTIVALENT ORAL ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Multivalent Oral Rotavirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Multivalent Oral Rotavirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Multivalent Oral Rotavirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Multivalent Oral Rotavirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Multivalent Oral Rotavirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Multivalent Oral Rotavirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Multivalent Oral Rotavirus Vaccine Sales Growth
4.4 APAC Multivalent Oral Rotavirus Vaccine Sales Growth
4.5 Europe Multivalent Oral Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Multivalent Oral Rotavirus Vaccine Sales by Country
5.1.1 Americas Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026)
5.3 Americas Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Multivalent Oral Rotavirus Vaccine Sales by Region
6.1.1 APAC Multivalent Oral Rotavirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Multivalent Oral Rotavirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026)
6.3 APAC Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Multivalent Oral Rotavirus Vaccine by Country
7.1.1 Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026)
7.3 Europe Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Multivalent Oral Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Multivalent Oral Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Multivalent Oral Rotavirus Vaccine
10.4 Industry Chain Structure of Multivalent Oral Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Multivalent Oral Rotavirus Vaccine Distributors
11.3 Multivalent Oral Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR MULTIVALENT ORAL ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Multivalent Oral Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Multivalent Oral Rotavirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Multivalent Oral Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Multivalent Oral Rotavirus Vaccine Forecast by Type (2027-2032)
12.7 Global Multivalent Oral Rotavirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Merck Multivalent Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Lanzhou Institute of Biological Products
13.2.1 Lanzhou Institute of Biological Products Company Information
13.2.2 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Lanzhou Institute of Biological Products Main Business Overview
13.2.5 Lanzhou Institute of Biological Products Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Multivalent Oral Rotavirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Multivalent Oral Rotavirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Multivalent Oral Rotavirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Multivalent Oral Rotavirus Vaccine Segment by Type
2.2.1 RV3
2.2.2 RV5
2.2.3 Multivalent Oral Rotavirus Vaccine Sales by Type
2.2.3.1 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Multivalent Oral Rotavirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Multivalent Oral Rotavirus Vaccine Sale Price by Type (2021-2026)
2.3 Multivalent Oral Rotavirus Vaccine Segment by Application
2.3.1 Government Institution
2.3.2 Private Sector
2.3.3 Other
2.3.4 Multivalent Oral Rotavirus Vaccine Sales by Application
2.3.4.1 Global Multivalent Oral Rotavirus Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global Multivalent Oral Rotavirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Multivalent Oral Rotavirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Multivalent Oral Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Multivalent Oral Rotavirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Multivalent Oral Rotavirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Multivalent Oral Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Multivalent Oral Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Multivalent Oral Rotavirus Vaccine Product Location Distribution
3.4.2 Players Multivalent Oral Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MULTIVALENT ORAL ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Multivalent Oral Rotavirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Multivalent Oral Rotavirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Multivalent Oral Rotavirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Multivalent Oral Rotavirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Multivalent Oral Rotavirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Multivalent Oral Rotavirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Multivalent Oral Rotavirus Vaccine Sales Growth
4.4 APAC Multivalent Oral Rotavirus Vaccine Sales Growth
4.5 Europe Multivalent Oral Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Multivalent Oral Rotavirus Vaccine Sales by Country
5.1.1 Americas Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026)
5.3 Americas Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Multivalent Oral Rotavirus Vaccine Sales by Region
6.1.1 APAC Multivalent Oral Rotavirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Multivalent Oral Rotavirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026)
6.3 APAC Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Multivalent Oral Rotavirus Vaccine by Country
7.1.1 Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026)
7.3 Europe Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Multivalent Oral Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Multivalent Oral Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Multivalent Oral Rotavirus Vaccine
10.4 Industry Chain Structure of Multivalent Oral Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Multivalent Oral Rotavirus Vaccine Distributors
11.3 Multivalent Oral Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR MULTIVALENT ORAL ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Multivalent Oral Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Multivalent Oral Rotavirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Multivalent Oral Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Multivalent Oral Rotavirus Vaccine Forecast by Type (2027-2032)
12.7 Global Multivalent Oral Rotavirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Merck Multivalent Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Lanzhou Institute of Biological Products
13.2.1 Lanzhou Institute of Biological Products Company Information
13.2.2 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Lanzhou Institute of Biological Products Main Business Overview
13.2.5 Lanzhou Institute of Biological Products Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Multivalent Oral Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Multivalent Oral Rotavirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of RV3
Table 4. Major Players of RV5
Table 5. Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Multivalent Oral Rotavirus Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Multivalent Oral Rotavirus Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Multivalent Oral Rotavirus Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Multivalent Oral Rotavirus Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Multivalent Oral Rotavirus Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Multivalent Oral Rotavirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Multivalent Oral Rotavirus Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Multivalent Oral Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Multivalent Oral Rotavirus Vaccine Products Offered
Table 22. Multivalent Oral Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Multivalent Oral Rotavirus Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Multivalent Oral Rotavirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Multivalent Oral Rotavirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Multivalent Oral Rotavirus Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Multivalent Oral Rotavirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Multivalent Oral Rotavirus Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Multivalent Oral Rotavirus Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Multivalent Oral Rotavirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Multivalent Oral Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Multivalent Oral Rotavirus Vaccine
Table 53. Key Industry Trends of Multivalent Oral Rotavirus Vaccine
Table 54. Multivalent Oral Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Multivalent Oral Rotavirus Vaccine Distributors List
Table 57. Multivalent Oral Rotavirus Vaccine Customer List
Table 58. Global Multivalent Oral Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Multivalent Oral Rotavirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Multivalent Oral Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Multivalent Oral Rotavirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Multivalent Oral Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Multivalent Oral Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Multivalent Oral Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Multivalent Oral Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Multivalent Oral Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Multivalent Oral Rotavirus Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Multivalent Oral Rotavirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Multivalent Oral Rotavirus Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Multivalent Oral Rotavirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Multivalent Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Merck Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Lanzhou Institute of Biological Products Basic Information, Multivalent Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
Table 79. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Lanzhou Institute of Biological Products Main Business
Table 81. Lanzhou Institute of Biological Products Latest Developments
Table 82. Serum Institute of India Basic Information, Multivalent Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
Table 84. Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Serum Institute of India Main Business
Table 86. Serum Institute of India Latest Developments
Table 1. Multivalent Oral Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Multivalent Oral Rotavirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of RV3
Table 4. Major Players of RV5
Table 5. Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Multivalent Oral Rotavirus Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Multivalent Oral Rotavirus Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Multivalent Oral Rotavirus Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Multivalent Oral Rotavirus Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Multivalent Oral Rotavirus Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Multivalent Oral Rotavirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Multivalent Oral Rotavirus Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Multivalent Oral Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Multivalent Oral Rotavirus Vaccine Products Offered
Table 22. Multivalent Oral Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Multivalent Oral Rotavirus Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Multivalent Oral Rotavirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Multivalent Oral Rotavirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Multivalent Oral Rotavirus Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Multivalent Oral Rotavirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Multivalent Oral Rotavirus Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Multivalent Oral Rotavirus Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Multivalent Oral Rotavirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Multivalent Oral Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Multivalent Oral Rotavirus Vaccine
Table 53. Key Industry Trends of Multivalent Oral Rotavirus Vaccine
Table 54. Multivalent Oral Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Multivalent Oral Rotavirus Vaccine Distributors List
Table 57. Multivalent Oral Rotavirus Vaccine Customer List
Table 58. Global Multivalent Oral Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Multivalent Oral Rotavirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Multivalent Oral Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Multivalent Oral Rotavirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Multivalent Oral Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Multivalent Oral Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Multivalent Oral Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Multivalent Oral Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Multivalent Oral Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Multivalent Oral Rotavirus Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Multivalent Oral Rotavirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Multivalent Oral Rotavirus Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Multivalent Oral Rotavirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Multivalent Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Merck Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Lanzhou Institute of Biological Products Basic Information, Multivalent Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
Table 79. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Lanzhou Institute of Biological Products Main Business
Table 81. Lanzhou Institute of Biological Products Latest Developments
Table 82. Serum Institute of India Basic Information, Multivalent Oral Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolios and Specifications
Table 84. Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Serum Institute of India Main Business
Table 86. Serum Institute of India Latest Developments
LIST OF FIGURES
Figure 1. Picture of Multivalent Oral Rotavirus Vaccine
Figure 2. Multivalent Oral Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Multivalent Oral Rotavirus Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Multivalent Oral Rotavirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Multivalent Oral Rotavirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Multivalent Oral Rotavirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Multivalent Oral Rotavirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of RV3
Figure 12. Product Picture of RV5
Figure 13. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type in 2026
Figure 14. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Multivalent Oral Rotavirus Vaccine Consumed in Government Institution
Figure 16. Global Multivalent Oral Rotavirus Vaccine Market: Government Institution (2021-2026) & (K Units)
Figure 17. Multivalent Oral Rotavirus Vaccine Consumed in Private Sector
Figure 18. Global Multivalent Oral Rotavirus Vaccine Market: Private Sector (2021-2026) & (K Units)
Figure 19. Multivalent Oral Rotavirus Vaccine Consumed in Other
Figure 20. Global Multivalent Oral Rotavirus Vaccine Market: Other (2021-2026) & (K Units)
Figure 21. Global Multivalent Oral Rotavirus Vaccine Sale Market Share by Application (2025)
Figure 22. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application in 2026
Figure 23. Multivalent Oral Rotavirus Vaccine Sales by Company in 2026 (K Units)
Figure 24. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Company in 2026
Figure 25. Multivalent Oral Rotavirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 26. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Company in 2026
Figure 27. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Multivalent Oral Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 30. Americas Multivalent Oral Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 31. APAC Multivalent Oral Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 32. APAC Multivalent Oral Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Europe Multivalent Oral Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 34. Europe Multivalent Oral Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Multivalent Oral Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Americas Multivalent Oral Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 38. Americas Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 39. Americas Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 40. Americas Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 41. United States Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Multivalent Oral Rotavirus Vaccine Sales Market Share by Region in 2026
Figure 46. APAC Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 47. APAC Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 48. APAC Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 49. China Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. India Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Multivalent Oral Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 57. Europe Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 58. Europe Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 59. Europe Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 60. Germany Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. France Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Egypt Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Multivalent Oral Rotavirus Vaccine in 2026
Figure 74. Manufacturing Process Analysis of Multivalent Oral Rotavirus Vaccine
Figure 75. Industry Chain Structure of Multivalent Oral Rotavirus Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Multivalent Oral Rotavirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 78. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Multivalent Oral Rotavirus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Multivalent Oral Rotavirus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Multivalent Oral Rotavirus Vaccine
Figure 2. Multivalent Oral Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Multivalent Oral Rotavirus Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Multivalent Oral Rotavirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Multivalent Oral Rotavirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Multivalent Oral Rotavirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Multivalent Oral Rotavirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of RV3
Figure 12. Product Picture of RV5
Figure 13. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type in 2026
Figure 14. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Multivalent Oral Rotavirus Vaccine Consumed in Government Institution
Figure 16. Global Multivalent Oral Rotavirus Vaccine Market: Government Institution (2021-2026) & (K Units)
Figure 17. Multivalent Oral Rotavirus Vaccine Consumed in Private Sector
Figure 18. Global Multivalent Oral Rotavirus Vaccine Market: Private Sector (2021-2026) & (K Units)
Figure 19. Multivalent Oral Rotavirus Vaccine Consumed in Other
Figure 20. Global Multivalent Oral Rotavirus Vaccine Market: Other (2021-2026) & (K Units)
Figure 21. Global Multivalent Oral Rotavirus Vaccine Sale Market Share by Application (2025)
Figure 22. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application in 2026
Figure 23. Multivalent Oral Rotavirus Vaccine Sales by Company in 2026 (K Units)
Figure 24. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Company in 2026
Figure 25. Multivalent Oral Rotavirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 26. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Company in 2026
Figure 27. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Multivalent Oral Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 30. Americas Multivalent Oral Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 31. APAC Multivalent Oral Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 32. APAC Multivalent Oral Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Europe Multivalent Oral Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 34. Europe Multivalent Oral Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Multivalent Oral Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Americas Multivalent Oral Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 38. Americas Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 39. Americas Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 40. Americas Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 41. United States Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Multivalent Oral Rotavirus Vaccine Sales Market Share by Region in 2026
Figure 46. APAC Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 47. APAC Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 48. APAC Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 49. China Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. India Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Multivalent Oral Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 57. Europe Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 58. Europe Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 59. Europe Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 60. Germany Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. France Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Egypt Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Multivalent Oral Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Multivalent Oral Rotavirus Vaccine in 2026
Figure 74. Manufacturing Process Analysis of Multivalent Oral Rotavirus Vaccine
Figure 75. Industry Chain Structure of Multivalent Oral Rotavirus Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Multivalent Oral Rotavirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 78. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Multivalent Oral Rotavirus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Multivalent Oral Rotavirus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share Forecast by Application (2027-2032)
